Used in pharmaceutical research as a key intermediate in the synthesis of serotonin and norepinephrine reuptake inhibitors. Shows potential in the development of central nervous system agents, particularly for treating depression and anxiety disorders. Its structure allows for high selectivity and binding affinity to monoamine transporters. Also explored in the design of radiolabeled derivatives for neuroimaging studies. Stable under standard storage conditions, making it suitable for long-term research applications.